Clinical Trials Directory

Trials / Completed

CompletedNCT07293377

Prospective Validation of ExCARE Model for 30-Day Postoperative Mortality

Prospective Validation of a Risk Stratification Model for Mortality Up to 30 Days After Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
3,000 (actual)
Sponsor
Hospital Nossa Senhora da Conceicao · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This prospective observational cohort study aims to validate the ExCARE risk model, derived from four preoperative variables (age, ASA-PS classification, procedure urgency, and surgical magnitude), for predicting in-hospital mortality up to 30 days post-non-cardiac surgery in a Brazilian tertiary hospital. A secondary validation of the SORT (Surgical Outcome Risk Tool) model will also be performed for comparison. The study involves no interventions and focuses on risk stratification to improve perioperative care allocation.

Detailed description

Approximately 300 million major surgical procedures are performed worldwide annually, with postoperative complications increasing costs and mortality. This study addresses the need for better perioperative risk stratification in Brazil, following WHO recommendations for universal health coverage. The ExCARE model, developed from 13,581 patients at Hospital de Clínicas de Porto Alegre (HCPA), showed good discriminative capacity (repeated in a 7,254-patient validation cohort). This external prospective validation at Hospital Nossa Senhora da Conceição will assess its performance in a new setting. Patients are stratified into four risk classes: Class I (\<2% mortality), Class II (2-5%), Class III (5-10%), Class IV (\>10%). Data will be analyzed using logistic regression, AUROC for discrimination, and Hosmer-Lemeshow test for calibration. Expected enrollment: 3,000 patients over 6 months.

Conditions

Timeline

Start date
2022-10-19
Primary completion
2025-07-30
Completion
2025-07-31
First posted
2025-12-19
Last updated
2025-12-19

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT07293377. Inclusion in this directory is not an endorsement.